Award Year / Program / Phase:2008 / SBIR / Phase I
Agency:HHS
Principal Investigator:
Award Amount:$99,999.00
Abstract:
DESCRIPTION (provided by applicant): The proposed work is to develop a therapeutic gene targeting agent for the treatment of HIV disease. Our approach is to use triplex-forming oligonucleotides (TFOs) and peptide nucleic acids (PNAs), which bind to duplex
DNA in a sequence-specific manner. Initial… More
DESCRIPTION (provided by applicant): This is a proposal to test the feasibility of using triplex-forming oligonucleotides to correct the sickle cell disease (SCD) mutation in human CD34+ cells. SCD is one of the most common human genetic diseases and is th
e result of one specific inherited mutation… More